Sign inJoin waitlistJoin the waitlist

MS

Michael Soileau

Physician · Texas Movement Disorder Specialists Pllc

Credentials: · · · ·

History

West Texas Rehabilitation Center
2024–Present

Rheumatology
2012–2014
Neurology
University of Michigan
2009–2012
McGovern Medical School at The University of Texas Health Science Center at Houston
2005–2009

Research

Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial
The Lancet Neurology · 2022 · First of 18 authors · Corresponding · 182 citations
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies
JAMA · 2024 · 170 citations
Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial
JAMA · 2021 · 144 citations

Rajesh Pahwa
7 papers
Jason Aldred
6 papers
Stuart Isaacson
6 papers
RK
Rajeev Kumar
5 papers
David Standaert
4 papers
Fernando Pagan
4 papers
Lan Luo
4 papers
PA
Pinky Agarwal
4 papers
PK
Pravin Khemani
4 papers
AM
Aristide Merola
3 papers
Holly Shill
3 papers
Irene Malaty
3 papers

Clinical trials

A Study to Investigate the Efficacy, Safety and Tolerability of Votoplam in Participants With Huntington's Disease
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
2026–2030